During the past decade, Kennestone Cancer Center at Wellstar Kennestone Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 30 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kennestone Cancer Center at Wellstar Kennestone Hospital" #1 sponsor was "SWOG Cancer Research Network" with 28 trials, followed by "SCRI Development Innovations, LLC" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kennestone Cancer Center at Wellstar Kennestone Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "Genentech, Inc." with 8 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Kennestone Cancer Center at Wellstar Kennestone Hospital" are "Breast Cancer" (15 trials), "Lung Cancer" (11 trials), "Lymphoma" (7 trials), "Colorectal Cancer" (5 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Kennestone Cancer Center at Wellstar Kennestone Hospital" in a lesser frequency.

Most popular intervention types in "Kennestone Cancer Center at Wellstar Kennestone Hospital" are "Drug" (45 trials), "Other" (21 trials), "Biological" (13 trials), "Radiation" (11 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "bevacizumab" (7 trials), "cyclophosphamide" (7 trials), "placebo" (7 trials), "Bevacizumab" (6 trials) and "biologic sample preservation procedure" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kennestone Cancer Center at Wellstar Kennestone Hospital" are 48 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kennestone Cancer Center at Wellstar Kennestone Hospital". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Kennestone Cancer Center at Wellstar Kennestone Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kennestone Cancer Center at Wellstar Kennestone Hospital, 2 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".